- Home
- Publications
- Publication Search
- Publication Details
Title
Glycans in HIV-1 vaccine design – engaging the shield
Authors
Keywords
HIV-1, envelope glycoproteins, glycobiology, neutralising antibody, B cell, vaccine
Journal
TRENDS IN MICROBIOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-03-09
DOI
10.1016/j.tim.2022.02.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A glycoside analog of mammalian oligomannose formulated with a TLR4-stimulating adjuvant elicits HIV-1 cross-reactive antibodies
- (2021) Jean-François Bruxelle et al. Scientific Reports
- Anti-glycan antibodies: roles in human disease
- (2021) J. Sebastian Temme et al. BIOCHEMICAL JOURNAL
- A cross-neutralizing antibody between HIV-1 and influenza virus
- (2021) Chang-Chun D. Lee et al. PLoS Pathogens
- Recent Advances in Lipopolysaccharide-Based Glycoconjugate Vaccines
- (2021) Henderson Zhu et al. Expert Review of Vaccines
- Directed Evolution of 2′-Fluoro-Modified, RNA-Supported Carbohydrate Clusters That Bind Tightly to HIV Antibody 2G12
- (2021) Richard L. Redman et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody
- (2020) Philipp Schommers et al. CELL
- Sialoglycans and Siglecs Can Shape the Tumor Immune Microenvironment
- (2020) Stephanie van de Wall et al. TRENDS IN IMMUNOLOGY
- Glycosylation as a tool for rational vaccine design
- (2020) Vivek Hariharan et al. BIOTECHNOLOGY AND BIOENGINEERING
- Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?
- (2020) P.J. Klasse et al. Cell Host & Microbe
- Networks of HIV-1 Envelope Glycans Maintain Antibody Epitopes in the Face of Glycan Additions and Deletions
- (2020) Gemma E. Seabright et al. STRUCTURE
- Serum alpha-mannosidase as an additional barrier to eliciting oligomannose-specific HIV-1-neutralizing antibodies
- (2020) Jean-François Bruxelle et al. Scientific Reports
- Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit Vaccines
- (2020) Bartek Nogal et al. Cell Reports
- Emergence and significance of carbohydrate-specific antibodies
- (2020) Katharina Kappler et al. GENES AND IMMUNITY
- Hitting the sweet spot: exploiting HIV-1 glycan shield for induction of broadly neutralizing antibodies
- (2020) Kshitij Wagh et al. Current Opinion in HIV and AIDS
- B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models
- (2020) Deli Huang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Oligomannose Glycopeptide Conjugates Elicit Antibodies Targeting the Glycan Core Rather than Its Extremities
- (2019) Dung N. Nguyen et al. ACS Central Science
- Glycosylation in health and disease
- (2019) Colin Reily et al. Nature Reviews Nephrology
- Exploitation of glycosylation in enveloped virus pathobiology
- (2019) Yasunori Watanabe et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Recent advances in carbohydrate-based cancer vaccines
- (2019) Ke-Tao Jin et al. BIOTECHNOLOGY LETTERS
- Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope
- (2019) Till Schoofs et al. IMMUNITY
- Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques
- (2019) Amelia Escolano et al. NATURE
- Roles for Golgi Glycans in Oogenesis and Spermatogenesis
- (2019) Ayodele Akintayo et al. Frontiers in Cell and Developmental Biology
- High-affinity anti-glycan antibodies: challenges and strategies
- (2019) Zinaida Polonskaya et al. CURRENT OPINION IN IMMUNOLOGY
- The sialoglycan-Siglec glyco-immune checkpoint – a target for improving innate and adaptive anti-cancer immunity
- (2019) Anne Bärenwaldt et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Multiple roles for HIV broadly neutralizing antibodies
- (2019) Barton F. Haynes et al. Science Translational Medicine
- A Neutralizing Antibody Recognizing Primarily N -Linked Glycan Targets the Silent Face of the HIV Envelope
- (2018) Tongqing Zhou et al. IMMUNITY
- Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses
- (2018) Manickam Ashokkumar et al. JOURNAL OF VIROLOGY
- Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope
- (2018) Christopher O. Barnes et al. Nature Communications
- HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope
- (2018) Daniela Fera et al. Nature Communications
- Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers
- (2018) Elise Landais et al. Retrovirology
- Glycoconjugate vaccines: Principles and mechanisms
- (2018) Rino Rappuoli Science Translational Medicine
- Site-Specific Glycosylation of Virion-Derived HIV-1 Env Is Mimicked by a Soluble Trimeric Immunogen
- (2018) Weston B. Struwe et al. Cell Reports
- Synthetic HIV V3 Glycopeptide Immunogen Carrying a N334 N-Glycan Induces Glycan-Dependent Antibodies with Promiscuous Site Recognition
- (2018) Hui Cai et al. JOURNAL OF MEDICINAL CHEMISTRY
- Recent progress in broadly neutralizing antibodies to HIV
- (2018) Devin Sok et al. NATURE IMMUNOLOGY
- Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core
- (2018) Andrew J Borst et al. eLife
- Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development
- (2017) Raiees Andrabi et al. IMMUNITY
- Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide
- (2017) S. Munir Alam et al. Science Translational Medicine
- Staged induction of HIV-1 glycan–dependent broadly neutralizing antibodies
- (2017) Mattia Bonsignori et al. Science Translational Medicine
- Bacterially derived synthetic mimetics of mammalian oligomannose prime antibody responses that neutralize HIV infectivity
- (2017) Ralph Pantophlet et al. Nature Communications
- Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects
- (2017) Laura F. Hutchins et al. Oncotarget
- Repertoire of BALB/c Mice Natural Anti-Carbohydrate Antibodies: Mice vs. Humans Difference, and Otherness of Individual Animals
- (2017) Daniel Bello-Gil et al. Frontiers in Immunology
- The fully synthetic MAG-Tn3 therapeutic vaccine containing the tetanus toxoid-derived TT830-844 universal epitope provides anti-tumor immunity
- (2016) Daphné Laubreton et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G
- (2016) Guillaume B.E. Stewart-Jones et al. CELL
- Carbohydrates as T-cell antigens with implications in health and disease
- (2016) Lina Sun et al. GLYCOBIOLOGY
- HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
- (2016) Jon M. Steichen et al. IMMUNITY
- Manipulation of the glycan-specific natural antibody repertoire for immunotherapy
- (2016) J. Stewart New et al. IMMUNOLOGICAL REVIEWS
- HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual
- (2016) Karen P. Coss et al. JOURNAL OF VIROLOGY
- Fragments of the V1/V2 domain of HIV-1 glycoprotein 120 engineered for improved binding to the broadly neutralizing PG9 antibody
- (2016) Javier F. Morales et al. MOLECULAR IMMUNOLOGY
- Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer
- (2016) J. H. Lee et al. SCIENCE
- Significant Impact of Immunogen Design on the Diversity of Antibodies Generated by Carbohydrate-Based Anticancer Vaccine
- (2015) Zhaojun Yin et al. ACS Chemical Biology
- The HIV glycan shield as a target for broadly neutralizing antibodies
- (2015) Katie J. Doores FEBS Journal
- Antibody recognition of carbohydrate epitopes
- (2015) Omid Haji-Ghassemi et al. GLYCOBIOLOGY
- Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans
- (2015) Fernando Garces et al. IMMUNITY
- Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design
- (2015) Raiees Andrabi et al. IMMUNITY
- Model Building and Refinement of a Natively Glycosylated HIV-1 Env Protein by High-Resolution Cryoelectron Microscopy
- (2015) Jeong Hyun Lee et al. STRUCTURE
- Antibodies to a conformational epitope on gp41 neutralize HIV-1 by destabilizing the Env spike
- (2015) Jeong Hyun Lee et al. Nature Communications
- Glycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodies
- (2015) Laura K. Pritchard et al. Nature Communications
- HIV broadly neutralizing antibody targets
- (2015) Constantinos Kurt Wibmer et al. Current Opinion in HIV and AIDS
- Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design
- (2015) Max Crispin et al. Current Opinion in Virology
- Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer
- (2015) Andréia Vasconcelos-dos-Santos et al. Frontiers in Oncology
- Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannose
- (2014) Robyn L Stanfield et al. GLYCOBIOLOGY
- Broadly Neutralizing HIV Antibodies Define a Glycan-Dependent Epitope on the Prefusion Conformation of gp41 on Cleaved Envelope Trimers
- (2014) Emilia Falkowska et al. IMMUNITY
- Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers
- (2014) Claudia Blattner et al. IMMUNITY
- HIV-1 Envelope Proteins and V1/V2 Domain Scaffolds with Mannose-5 to Improve the Magnitude and Quality of Protective Antibody Responses to HIV-1
- (2014) Javier F. Morales et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques
- (2014) Masashi Shingai et al. JOURNAL OF EXPERIMENTAL MEDICINE
- HIV-1 Envelope Glycan Moieties Modulate HIV-1 Transmission
- (2014) R. Shen et al. JOURNAL OF VIROLOGY
- Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface
- (2014) Jinghe Huang et al. NATURE
- Structure and immune recognition of trimeric pre-fusion HIV-1 Env
- (2014) Marie Pancera et al. NATURE
- Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies
- (2014) Nicole A. Doria-Rose et al. NATURE
- Kinetic Properties of Carbohydrate-Lectin Interactions: FimH Antagonists
- (2013) Meike Scharenberg et al. ChemMedChem
- Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16
- (2013) Marie Pancera et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
- (2013) Leopold Kong et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A Bacterial Lipooligosaccharide that Naturally Mimics the Epitope of the HIV-Neutralizing Antibody 2G12 as a Template for Vaccine Design
- (2012) Brenda E. Clark et al. CHEMISTRY & BIOLOGY
- Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
- (2012) B. Moldt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular disease
- (2011) T. Grader-Beck et al. ANNALS OF THE RHEUMATIC DISEASES
- HIV-1 Envelope Glycoprotein Biosynthesis, Trafficking, and Incorporation
- (2011) Mary Ann Checkley et al. JOURNAL OF MOLECULAR BIOLOGY
- Characterization of Glycosylation Profiles of HIV-1 Transmitted/Founder Envelopes by Mass Spectrometry
- (2011) E. P. Go et al. JOURNAL OF VIROLOGY
- Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9
- (2011) Jason S. McLellan et al. NATURE
- A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield
- (2011) R. Pejchal et al. SCIENCE
- Defining Criteria for Oligomannose Immunogens for HIV Using Icosahedral Virus Capsid Scaffolds
- (2010) Rena D. Astronomo et al. CHEMISTRY & BIOLOGY
- Three Doses of an Experimental Detoxified L3-Derived Lipooligosaccharide Meningococcal Vaccine Offer Good Safety but Low Immunogenicity in Healthy Young Adults
- (2010) P. Bonvehi et al. Clinical and Vaccine Immunology
- Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans
- (2010) D Cameron Dunlop et al. GLYCOBIOLOGY
- Yeast-Elicited Cross-Reactive Antibodies to HIV Env Glycans Efficiently Neutralize Virions Expressing Exclusively High-Mannose N-Linked Glycans
- (2010) C. Agrawal-Gamse et al. JOURNAL OF VIROLOGY
- Variable Loop Glycan Dependency of the Broad and Potent HIV-1-Neutralizing Antibodies PG9 and PG16
- (2010) Katie J. Doores et al. JOURNAL OF VIROLOGY
- Carbohydrate vaccines: developing sweet solutions to sticky situations?
- (2010) Rena D. Astronomo et al. NATURE REVIEWS DRUG DISCOVERY
- A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity
- (2010) K. J. Doores et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
- (2010) T. Zhou et al. SCIENCE
- Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
- (2009) L. M. Walker et al. SCIENCE
- Antigenic mimicry of the HIV envelope by AIDS-associated pathogens
- (2008) D Cameron Dunlop et al. AIDS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More